American Century Companies’s Novartis NVS Stock Holding History

American Century Companies's NVS Position: Q1 2026 in Review

American Century Companies increased its Novartis (NVS) stake by 14% in Q1 2026, buying an estimated $13M and bringing the position to 703,178 shares worth $107M. The position accounts for 0.06% of the portfolio, ranked #395.

American Century Companies first reported a position in NVS in Q1 2019 and has held it in 29 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

• American Century Companies held 703,178 shares of Novartis worth $107M as of Q1 2026.
• American Century Companies bought 84,910 Novartis shares in Q1 2026, an estimated $13M.
• Novartis made up 0.06% of American Century Companies's portfolio in Q1 2026, its #395 holding.
• American Century Companies first reported a position in Novartis in Q1 2019 and has held it in 29 quarters since.
• 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.